These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 33664640)

  • 21. The Multiple Causes of Stroke in Atrial Fibrillation: Thinking Broadly.
    D'Souza A; Butcher KS; Buck BH
    Can J Cardiol; 2018 Nov; 34(11):1503-1511. PubMed ID: 30404753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks.
    Aguilar MI; Hart R; Pearce LA
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006186. PubMed ID: 17636831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
    Bahit MC; Sacco RL; Easton JD; Meyerhoff J; Cronin L; Kleine E; Grauer C; Brueckmann M; Diener HC; Lopes RD; Brainin M; Lyrer P; Wachter R; Segura T; Granger CB;
    Circulation; 2021 Nov; 144(22):1738-1746. PubMed ID: 34649459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial Fibrillation Detected After Stroke and Transient Ischemic Attack: A Novel Clinical Concept Challenging Current Views.
    Sposato LA; Chaturvedi S; Hsieh CY; Morillo CA; Kamel H
    Stroke; 2022 Mar; 53(3):e94-e103. PubMed ID: 34986652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial cardiopathy predicts detection of atrial fibrillation in embolic stroke of undetermined source: real-life data.
    Silva AR; Pires C; Meira-Carvalho F; Santos M; Antunes NP; Alves JN; Ferreira C; Pinho J
    Neurol Sci; 2022 Apr; 43(4):2383-2386. PubMed ID: 34708261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with oral anticoagulant prescription status among patients with a new diagnosis of atrial fibrillation.
    Manning E; Burns K; Laurie M; Patten L; Ho M; Sandhu A
    Clin Cardiol; 2023 Aug; 46(8):937-941. PubMed ID: 37401357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of stroke or transient ischemic attack after atrial fibrillation ablation with oral anticoagulant use guided by ECG monitoring and pulse assessment.
    Riley MP; Zado E; Hutchinson MD; Lin D; Bala R; Garcia FC; Callans DJ; Cooper JM; Verdino RJ; Dixit S; Marchlinski FE
    J Cardiovasc Electrophysiol; 2014 Jun; 25(6):591-6. PubMed ID: 24533561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk.
    Potpara TS; Lip GY
    Prog Cardiovasc Dis; 2015; 58(2):177-94. PubMed ID: 26162958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate.
    Goldberger JJ; Arora R; Green D; Greenland P; Lee DC; Lloyd-Jones DM; Markl M; Ng J; Shah SJ
    Circulation; 2015 Jul; 132(4):278-91. PubMed ID: 26216085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catheter ablation in combination with left atrial appendage closure for atrial fibrillation.
    Swaans MJ; Alipour A; Rensing BJ; Post MC; Boersma LV
    J Vis Exp; 2013 Feb; (72):e3818. PubMed ID: 23486416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left atrial appendage closure for prevention of cardioembolic events.
    Gloekler S; Meier B; Windecker S
    Swiss Med Wkly; 2016; 146():w14298. PubMed ID: 27244534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial Cardiopathy and Stroke Prevention.
    Elkind MSV
    Curr Cardiol Rep; 2018 Sep; 20(11):103. PubMed ID: 30209635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators.
    Zabalgoitia M; Halperin JL; Pearce LA; Blackshear JL; Asinger RW; Hart RG
    J Am Coll Cardiol; 1998 Jun; 31(7):1622-6. PubMed ID: 9626843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silent Atrial Fibrillation: A Critical Review.
    Barbarossa A; Guerra F; Capucci A
    J Atr Fibrillation; 2014; 7(3):1138. PubMed ID: 27957123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation.
    Onalan O; Crystal E
    Stroke; 2007 Feb; 38(2 Suppl):624-30. PubMed ID: 17261703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
    Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
    Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial CARdiac Magnetic resonance imaging in patients with embolic stroke of unknown source without documented Atrial Fibrillation (CARM-AF): Study design and clinical protocol.
    Kotadia ID; O'Dowling R; Aboagye A; Sim I; O'Hare D; Lemus-Solis JA; Roney CH; Dweck M; Chiribiri A; Plein S; Sztriha L; Scott P; Harrison J; Ramsay D; Birns J; Somerville P; Bhalla A; Niederer S; O'Neill M; Williams SE
    Heart Rhythm O2; 2022 Apr; 3(2):196-203. PubMed ID: 35496458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.
    Piccini JP; Stevens SR; Chang Y; Singer DE; Lokhnygina Y; Go AS; Patel MR; Mahaffey KW; Halperin JL; Breithardt G; Hankey GJ; Hacke W; Becker RC; Nessel CC; Fox KA; Califf RM;
    Circulation; 2013 Jan; 127(2):224-32. PubMed ID: 23212720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Mailing Educational Material to Patients With Atrial Fibrillation and Their Clinicians on Use of Oral Anticoagulants: A Randomized Clinical Trial.
    Pokorney SD; Cocoros N; Al-Khalidi HR; Haynes K; Li S; Al-Khatib SM; Corrigan-Curay J; Driscoll MR; Garcia C; Calvert SB; Harkins T; Jin R; Knecht D; Levenson M; Lin ND; Martin D; McCall D; McMahill-Walraven C; Nair V; Parlett L; Petrone A; Temple R; Zhang R; Zhou Y; Platt R; Granger CB
    JAMA Netw Open; 2022 May; 5(5):e2214321. PubMed ID: 35639381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.